Ranbaxy Unit Launches Generic Lipitor In South Africa
This article was originally published in PharmAsia News
Executive Summary
A Ranbaxy Laboratories subsidiary in South Africa has begun marketing a generic version of U.S.-Based Pfizer's Lipitor (atorvastatin) for treating high cholesterol